The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tissue Mass Spectrometry Imaging System Market Research Report 2024
Synopsis
Mass spectrometry imaging is an imaging method based on mass spectrometry technology. This method directly scans biological samples for imaging through mass spectrometry, and can simultaneously analyze the spatial distribution characteristics of hundreds of molecules on the same tissue slice or tissue chip. In simple terms, mass spectrometry imaging technology is a method of imaging with the help of mass spectrometry, coupled with the control of specialized mass spectrometry imaging software, using a mass spectrometer that analyzes the standard molecular weight of biomolecules by determining the mass-to-charge ratio. The tissue mass spectrometry imaging system has both high-parameter single-cell suspension detection functions and tissue imaging functions. Maximize the advantages of mass spectrometry flow cytometry (CyTOF) ultra-high number of detection channels in tissue imaging research, and its performance far exceeds traditional immunohistochemistry or immunofluorescence techniques.
Global Tissue Mass Spectrometry Imaging System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tissue Mass Spectrometry Imaging System market research.
Key manufacturers engaged in the Tissue Mass Spectrometry Imaging System industry include Standard BioTools, Waters Corporation, Ionpath, JEOL, SHIMADZU, TransMIT GmbH, Thermo Fisher Scientific, Impact Scientific Instrument and mProbe, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tissue Mass Spectrometry Imaging System were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tissue Mass Spectrometry Imaging System market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Mass Spectrometry Imaging System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Standard BioTools
Waters Corporation
Ionpath
JEOL
SHIMADZU
TransMIT GmbH
Thermo Fisher Scientific
Impact Scientific Instrument
mProbe
Segment by Type
Detection Channel Is Less Than 100
Detection Channel Is Greater Than 100
Segment by Application
Neuroscience
Pathology
Nutrition
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tissue Mass Spectrometry Imaging System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Mass spectrometry imaging is an imaging method based on mass spectrometry technology. This method directly scans biological samples for imaging through mass spectrometry, and can simultaneously analyze the spatial distribution characteristics of hundreds of molecules on the same tissue slice or tissue chip. In simple terms, mass spectrometry imaging technology is a method of imaging with the help of mass spectrometry, coupled with the control of specialized mass spectrometry imaging software, using a mass spectrometer that analyzes the standard molecular weight of biomolecules by determining the mass-to-charge ratio. The tissue mass spectrometry imaging system has both high-parameter single-cell suspension detection functions and tissue imaging functions. Maximize the advantages of mass spectrometry flow cytometry (CyTOF) ultra-high number of detection channels in tissue imaging research, and its performance far exceeds traditional immunohistochemistry or immunofluorescence techniques.
Global Tissue Mass Spectrometry Imaging System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tissue Mass Spectrometry Imaging System market research.
Key manufacturers engaged in the Tissue Mass Spectrometry Imaging System industry include Standard BioTools, Waters Corporation, Ionpath, JEOL, SHIMADZU, TransMIT GmbH, Thermo Fisher Scientific, Impact Scientific Instrument and mProbe, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tissue Mass Spectrometry Imaging System were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tissue Mass Spectrometry Imaging System market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Mass Spectrometry Imaging System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Standard BioTools
Waters Corporation
Ionpath
JEOL
SHIMADZU
TransMIT GmbH
Thermo Fisher Scientific
Impact Scientific Instrument
mProbe
Segment by Type
Detection Channel Is Less Than 100
Detection Channel Is Greater Than 100
Segment by Application
Neuroscience
Pathology
Nutrition
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tissue Mass Spectrometry Imaging System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Tissue Mass Spectrometry Imaging System Market Overview
1.1 Product Overview and Scope of Tissue Mass Spectrometry Imaging System
1.2 Tissue Mass Spectrometry Imaging System Segment by Type
1.2.1 Global Tissue Mass Spectrometry Imaging System Market Value Comparison by Type (2023-2029)
1.2.2 Detection Channel Is Less Than 100
1.2.3 Detection Channel Is Greater Than 100
1.3 Tissue Mass Spectrometry Imaging System Segment by Application
1.3.1 Global Tissue Mass Spectrometry Imaging System Market Value by Application: (2023-2029)
1.3.2 Neuroscience
1.3.3 Pathology
1.3.4 Nutrition
1.3.5 Others
1.4 Global Tissue Mass Spectrometry Imaging System Market Size Estimates and Forecasts
1.4.1 Global Tissue Mass Spectrometry Imaging System Revenue 2018-2029
1.4.2 Global Tissue Mass Spectrometry Imaging System Sales 2018-2029
1.4.3 Global Tissue Mass Spectrometry Imaging System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tissue Mass Spectrometry Imaging System Market Competition by Manufacturers
2.1 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tissue Mass Spectrometry Imaging System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tissue Mass Spectrometry Imaging System Average Price by Manufacturers (2018-2023)
2.4 Global Tissue Mass Spectrometry Imaging System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tissue Mass Spectrometry Imaging System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tissue Mass Spectrometry Imaging System, Product Type & Application
2.7 Tissue Mass Spectrometry Imaging System Market Competitive Situation and Trends
2.7.1 Tissue Mass Spectrometry Imaging System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tissue Mass Spectrometry Imaging System Players Market Share by Revenue
2.7.3 Global Tissue Mass Spectrometry Imaging System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tissue Mass Spectrometry Imaging System Retrospective Market Scenario by Region
3.1 Global Tissue Mass Spectrometry Imaging System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tissue Mass Spectrometry Imaging System Global Tissue Mass Spectrometry Imaging System Sales by Region: 2018-2029
3.2.1 Global Tissue Mass Spectrometry Imaging System Sales by Region: 2018-2023
3.2.2 Global Tissue Mass Spectrometry Imaging System Sales by Region: 2024-2029
3.3 Global Tissue Mass Spectrometry Imaging System Global Tissue Mass Spectrometry Imaging System Revenue by Region: 2018-2029
3.3.1 Global Tissue Mass Spectrometry Imaging System Revenue by Region: 2018-2023
3.3.2 Global Tissue Mass Spectrometry Imaging System Revenue by Region: 2024-2029
3.4 North America Tissue Mass Spectrometry Imaging System Market Facts & Figures by Country
3.4.1 North America Tissue Mass Spectrometry Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tissue Mass Spectrometry Imaging System Sales by Country (2018-2029)
3.4.3 North America Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tissue Mass Spectrometry Imaging System Market Facts & Figures by Country
3.5.1 Europe Tissue Mass Spectrometry Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tissue Mass Spectrometry Imaging System Sales by Country (2018-2029)
3.5.3 Europe Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tissue Mass Spectrometry Imaging System Market Facts & Figures by Country
3.6.1 Asia Pacific Tissue Mass Spectrometry Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tissue Mass Spectrometry Imaging System Sales by Country (2018-2029)
3.6.3 Asia Pacific Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tissue Mass Spectrometry Imaging System Market Facts & Figures by Country
3.7.1 Latin America Tissue Mass Spectrometry Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tissue Mass Spectrometry Imaging System Sales by Country (2018-2029)
3.7.3 Latin America Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tissue Mass Spectrometry Imaging System Market Facts & Figures by Country
3.8.1 Middle East and Africa Tissue Mass Spectrometry Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tissue Mass Spectrometry Imaging System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tissue Mass Spectrometry Imaging System Sales by Type (2018-2029)
4.1.1 Global Tissue Mass Spectrometry Imaging System Sales by Type (2018-2023)
4.1.2 Global Tissue Mass Spectrometry Imaging System Sales by Type (2024-2029)
4.1.3 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Type (2018-2029)
4.2 Global Tissue Mass Spectrometry Imaging System Revenue by Type (2018-2029)
4.2.1 Global Tissue Mass Spectrometry Imaging System Revenue by Type (2018-2023)
4.2.2 Global Tissue Mass Spectrometry Imaging System Revenue by Type (2024-2029)
4.2.3 Global Tissue Mass Spectrometry Imaging System Revenue Market Share by Type (2018-2029)
4.3 Global Tissue Mass Spectrometry Imaging System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tissue Mass Spectrometry Imaging System Sales by Application (2018-2029)
5.1.1 Global Tissue Mass Spectrometry Imaging System Sales by Application (2018-2023)
5.1.2 Global Tissue Mass Spectrometry Imaging System Sales by Application (2024-2029)
5.1.3 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Application (2018-2029)
5.2 Global Tissue Mass Spectrometry Imaging System Revenue by Application (2018-2029)
5.2.1 Global Tissue Mass Spectrometry Imaging System Revenue by Application (2018-2023)
5.2.2 Global Tissue Mass Spectrometry Imaging System Revenue by Application (2024-2029)
5.2.3 Global Tissue Mass Spectrometry Imaging System Revenue Market Share by Application (2018-2029)
5.3 Global Tissue Mass Spectrometry Imaging System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Standard BioTools
6.1.1 Standard BioTools Corporation Information
6.1.2 Standard BioTools Description and Business Overview
6.1.3 Standard BioTools Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Standard BioTools Tissue Mass Spectrometry Imaging System Product Portfolio
6.1.5 Standard BioTools Recent Developments/Updates
6.2 Waters Corporation
6.2.1 Waters Corporation Corporation Information
6.2.2 Waters Corporation Description and Business Overview
6.2.3 Waters Corporation Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Waters Corporation Tissue Mass Spectrometry Imaging System Product Portfolio
6.2.5 Waters Corporation Recent Developments/Updates
6.3 Ionpath
6.3.1 Ionpath Corporation Information
6.3.2 Ionpath Description and Business Overview
6.3.3 Ionpath Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ionpath Tissue Mass Spectrometry Imaging System Product Portfolio
6.3.5 Ionpath Recent Developments/Updates
6.4 JEOL
6.4.1 JEOL Corporation Information
6.4.2 JEOL Description and Business Overview
6.4.3 JEOL Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 JEOL Tissue Mass Spectrometry Imaging System Product Portfolio
6.4.5 JEOL Recent Developments/Updates
6.5 SHIMADZU
6.5.1 SHIMADZU Corporation Information
6.5.2 SHIMADZU Description and Business Overview
6.5.3 SHIMADZU Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 SHIMADZU Tissue Mass Spectrometry Imaging System Product Portfolio
6.5.5 SHIMADZU Recent Developments/Updates
6.6 TransMIT GmbH
6.6.1 TransMIT GmbH Corporation Information
6.6.2 TransMIT GmbH Description and Business Overview
6.6.3 TransMIT GmbH Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 TransMIT GmbH Tissue Mass Spectrometry Imaging System Product Portfolio
6.6.5 TransMIT GmbH Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.6.1 Thermo Fisher Scientific Corporation Information
6.6.2 Thermo Fisher Scientific Description and Business Overview
6.6.3 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 Impact Scientific Instrument
6.8.1 Impact Scientific Instrument Corporation Information
6.8.2 Impact Scientific Instrument Description and Business Overview
6.8.3 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Product Portfolio
6.8.5 Impact Scientific Instrument Recent Developments/Updates
6.9 mProbe
6.9.1 mProbe Corporation Information
6.9.2 mProbe Description and Business Overview
6.9.3 mProbe Tissue Mass Spectrometry Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 mProbe Tissue Mass Spectrometry Imaging System Product Portfolio
6.9.5 mProbe Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tissue Mass Spectrometry Imaging System Industry Chain Analysis
7.2 Tissue Mass Spectrometry Imaging System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tissue Mass Spectrometry Imaging System Production Mode & Process
7.4 Tissue Mass Spectrometry Imaging System Sales and Marketing
7.4.1 Tissue Mass Spectrometry Imaging System Sales Channels
7.4.2 Tissue Mass Spectrometry Imaging System Distributors
7.5 Tissue Mass Spectrometry Imaging System Customers
8 Tissue Mass Spectrometry Imaging System Market Dynamics
8.1 Tissue Mass Spectrometry Imaging System Industry Trends
8.2 Tissue Mass Spectrometry Imaging System Market Drivers
8.3 Tissue Mass Spectrometry Imaging System Market Challenges
8.4 Tissue Mass Spectrometry Imaging System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
